JPY 762.0
(-4.87%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - JPY | 0.0% |
2022 | - JPY | -100.0% |
2021 | 467.84 Million JPY | 5.25% |
2020 | 444.51 Million JPY | -5.34% |
2019 | 469.6 Million JPY | 0.0% |
2018 | - JPY | 0.0% |
2017 | - JPY | -100.0% |
2016 | 495.53 Million JPY | 0.0% |
2015 | - JPY | 0.0% |
2014 | - JPY | 0.0% |
2013 | - JPY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - JPY | 0.0% |
2024 Q2 | - JPY | 0.0% |
2023 Q2 | - JPY | 0.0% |
2023 Q4 | - JPY | 0.0% |
2023 FY | - JPY | 0.0% |
2023 Q1 | - JPY | 0.0% |
2023 Q3 | - JPY | 0.0% |
2022 Q4 | - JPY | 0.0% |
2022 Q3 | - JPY | 0.0% |
2022 FY | - JPY | -100.0% |
2022 Q2 | - JPY | -100.0% |
2022 Q1 | 495.71 Million JPY | 5.96% |
2021 FY | 467.84 Million JPY | 5.25% |
2021 Q4 | 467.84 Million JPY | 0.91% |
2021 Q2 | 453.51 Million JPY | 0.28% |
2021 Q1 | 452.25 Million JPY | 1.74% |
2021 Q3 | 463.62 Million JPY | 2.23% |
2020 Q2 | 448.77 Million JPY | -1.98% |
2020 FY | 444.51 Million JPY | -5.34% |
2020 Q4 | 444.51 Million JPY | -0.09% |
2020 Q3 | 444.92 Million JPY | -0.86% |
2020 Q1 | 457.85 Million JPY | -2.5% |
2019 FY | 469.6 Million JPY | 0.0% |
2019 Q3 | 204.67 Million JPY | -3.18% |
2019 Q4 | 469.6 Million JPY | 129.44% |
2019 Q2 | 211.39 Million JPY | 0.0% |
2019 Q1 | - JPY | 0.0% |
2018 FY | - JPY | 0.0% |
2018 Q4 | - JPY | 0.0% |
2018 Q3 | - JPY | 0.0% |
2018 Q2 | - JPY | 0.0% |
2018 Q1 | - JPY | 0.0% |
2017 Q1 | - JPY | -100.0% |
2017 FY | - JPY | -100.0% |
2017 Q4 | - JPY | 0.0% |
2017 Q3 | - JPY | 0.0% |
2017 Q2 | - JPY | 0.0% |
2016 Q2 | - JPY | 0.0% |
2016 FY | 495.53 Million JPY | 0.0% |
2016 Q3 | - JPY | 0.0% |
2016 Q1 | - JPY | 0.0% |
2016 Q4 | 495.88 Million JPY | 0.0% |
2015 Q2 | - JPY | -100.0% |
2015 Q1 | 483 Thousand JPY | 0.0% |
2015 Q4 | - JPY | 0.0% |
2015 FY | - JPY | 0.0% |
2015 Q3 | - JPY | 0.0% |
2014 FY | - JPY | 0.0% |
2014 Q4 | - JPY | 0.0% |
2013 FY | - JPY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
KOHJIN BIO CO LTD | 683.01 Million JPY | 100.0% |
PRISM BioLab Co.,LTD | 17.92 Million JPY | 100.0% |
GNI Group Ltd. | 2.33 Billion JPY | 100.0% |
Linical Co., Ltd. | - JPY | NaN% |
Trans Genic Inc. | 2.22 Billion JPY | 100.0% |
MEDINET Co., Ltd. | 67.48 Million JPY | 100.0% |
Soiken Holdings Inc. | 1.12 Billion JPY | 100.0% |
Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 100.0% |
AnGes, Inc. | 1.61 Billion JPY | 100.0% |
OncoTherapy Science, Inc. | 73.99 Million JPY | 100.0% |
Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 100.0% |
Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 100.0% |
NanoCarrier Co., Ltd. | 184 Thousand JPY | 100.0% |
Carna Biosciences, Inc. | 140.14 Million JPY | 100.0% |
CanBas Co., Ltd. | 728 Thousand JPY | 100.0% |
D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 100.0% |
RaQualia Pharma Inc. | 147.93 Million JPY | 100.0% |
Chiome Bioscience Inc. | 64.1 Million JPY | 100.0% |
Kidswell Bio Corporation | 875.65 Million JPY | 100.0% |
PeptiDream Inc. | 2.4 Billion JPY | 100.0% |
Oncolys BioPharma Inc. | 5.34 Million JPY | 100.0% |
Ribomic Inc. | 2.27 Million JPY | 100.0% |
Healios K.K. | - JPY | NaN% |
BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | 100.0% |
Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | 100.0% |
Delta-Fly Pharma, Inc. | - JPY | NaN% |
StemRIM | 29 Million JPY | 100.0% |
CellSource Co., Ltd. | 305.92 Million JPY | 100.0% |
FunPep Company Limited | 25.54 Million JPY | 100.0% |
Kringle Pharma, Inc. | 364.05 Million JPY | 100.0% |
Stella Pharma Corporation | 1.11 Billion JPY | 100.0% |
TMS Co., Ltd. | 50.02 Million JPY | 100.0% |
Noile-Immune Biotech Inc. | 20.9 Million JPY | 100.0% |
Cuorips Inc. | 1.04 Million JPY | 100.0% |
K Pharma,Inc. | 10.79 Million JPY | 100.0% |
Takara Bio Inc. | 11.85 Billion JPY | 100.0% |
ReproCELL Incorporated | 248.14 Million JPY | 100.0% |
PhoenixBio Co., Ltd. | 450.58 Million JPY | 100.0% |
StemCell Institute Inc. | 42.26 Million JPY | 100.0% |
Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 100.0% |
CellSeed Inc. | 46.19 Million JPY | 100.0% |